在患有透心性心力衰竭的患者中,左心室的系统性表现,功能和收缩性
Catalin F Baicu1, Michael R Zile, Gerard P Aurigemma
1Division of Cardiology, Department of Medicine, Medical University of South Carolina and RHJ Department of Veterans Affairs Medical Center, Charleston, SC 29425, USA.
Circulation
|April 27, 2005
概括
扩张性心力衰竭 (DHF) 患者表现出正常的左心室 (LV) 系统性表现,功能和收缩性. 这些发现表明DHF的病理生理学与缩异常无关.
科学领域:
- 心脏病学 心脏病学
- 心血管生理学心血管生理学
背景情况:
- 扩张性心力衰竭 (DHF) 的特征是左心室 (LV) 扩张功能受损,包括延迟放松和增加性.
- 这些腹性异常与LV心性表现,功能和收缩性之间的关联仍然不完全理解.
研究的目的:
- 在被诊断患有透心性心力衰竭 (DHF) 的患者中调查 LV 系统性特性.
- 为了确定在DHF中是否存在LV缩性表现,功能或收缩性的异常.
主要方法:
- 分析了75名高血压患者和75名健康对照者的心声和心脏导管数据.
- 评估的指数包括中风工作,预加载可招募的中风工作,喷射率,缩压缩关系,末缩压缩量关系和峰值 (+) dP/dt.
主要成果:
- 与对照组相比,LV缩性质在DHF患者中被发现是正常的.
- 具体措施,如中风工作 (P=0.26),预加载可招募的中风工作 (P=0.13),和峰值 (+) dP/dt (P=0.54),没有显著差异.
- 末压力-体积关系在DHF患者中升高,而缩压力-内心脏分数缩短关系相似.
结论:
- 患有DHF的患者表现出正常的左心室缩性表现,功能和收缩性.
- 底层DHF的病理生理学似乎不涉及左心室的这些缩性质的显著异常.
相关概念视频
Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


